Showing results (401-410 of 831) with videos related to

Sort By:
Pageof 84
Journal of Biotechnology|March 13, 2024
In vitro synthesis of oryzamutaic acid H using recombinant L-lysine ε-dehydrogenase from Agrobacterium tumefaciensYuta Horie, Makoto Uchikata, Sachie Ueda, et al.
Diagnostic Pathology|July 3, 2024
Primary lung chordoma: a case reportNaoko Shigeta, Tetsuya Isaka, Kyoko Ono, et al.
Case Reports in Endocrinology|May 27, 2020
A Case of Unresectable Papillary Thyroid Carcinoma Treated with Lenvatinib as Neoadjuvant ChemotherapyHiroyuki Iwasaki, Soji Toda, Hiroyuki Ito, et al.
Pacing and Clinical Electrophysiology : PACE|May 15, 2015
Daily Dysfunction of Autonomic Regulation Based on Ambulatory Blood Pressure Monitoring in Patients with Neurally Mediated Reflex SyncopeYoshimi Onishi, Yoshino Minoura, Yuta Chiba, et al.
Journal of Thoracic Disease|August 23, 2021
Anatomical location and number of metastatic lymph nodes for prognosis of non-small cell lung cancerJoji Samejima, Hiroyuki Ito, Takuya Nagashima, et al.
Diabetes Research and Clinical Practice|October 30, 2007
Waist circumference is the main determinant of elevated C-reactive protein in metabolic syndromeHirofumi Nakamura, Hiroyuki Ito, Yuhko Egami, et al.
Nihon Jinzo Gakkai Shi|April 22, 2003
[Successful treatment of combination therapy using an angiotensin-converting enzyme inhibitor and an angiotensin II receptor blocker in a patient with IgA nephropathy]Taro Horino, Hiroyuki Ito, Noriyasu Tanimoto, et al.
Internal Medicine (Tokyo, Japan)|November 30, 2020
Early Improvement of Non-islet Cell Tumor Hypoglycemia by Chemotherapy Using Lenvatinib in a Case with Type 2 Diabetes and Hepatocellular Carcinoma Producing Big IGF-IITakuma Izutsu, Hiroyuki Ito, Izumi Fukuda, et al.
Internal Medicine (Tokyo, Japan)|July 14, 2012
Non-alcoholic fatty liver disease is an independent predictor for macroangiopathy in Japanese type 2 diabetic patients: a cross-sectional studyYuichiro Takeuchi, Hiroyuki Ito, Yuko Komatsu, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|July 17, 2026
Comparative effectiveness of mepolizumab and omalizumab in patients eligible for both: a retrospective cohort studyTatsuya Nagai, Naoki Inoshima, Hiroki Matsui, et al.
Pageof 84